Swiss fragrance major Givaudan has introduced HarmoniScentz™, a neurobiology-backed fragrance design technology platform for formulating stress-alleviating scents, alongside OrbiScanz™, a proprietary wearable device d...
Swiss fragrance major Givaudan has introduced HarmoniScentz™, a neurobiology-backed fragrance design technology platform for formulating stress-alleviating scents, alongside OrbiScanz™, a proprietary wearable device designed to monitor real-time physiological stress responses to scent exposure, in March 2025. The dual launch spans fine fragrance, personal care, and home care, offering beauty and consumer goods brands a data-driven system for functional scent creation and biometric verification.
Translating Neurobiology into Perfumery
HarmoniScentz™ operates by translating neurobiological data into concrete parameters for perfumers. Rather than relying solely on traditional olfactive pyramids or qualitative consumer panel testing, the platform uses neurobiological data to guide formulation toward measurable stress alleviation.
To validate these formulations, Givaudan developed OrbiScanz™, a wearable device that captures live biometric feedback from individuals exposed to specific scent compounds. By measuring real-time physiological stress reduction during fragrance exposure, the hardware allows the company to quantify emotional and physical responses. According to Givaudan, HarmoniScentz™ provides perfumers with the empirical data needed to design stress-relieving scents, while OrbiScanz™ serves as the measurement tool to verify efficacy.
Quantifying Claims Across Categories
The dual launch targets the growing functional fragrance market, where consumer purchasing decisions are increasingly driven by emotional, mood-enhancing, and wellness benefits alongside traditional scent preferences. By applying HarmoniScentz™ across fine fragrance, personal care, and home care, Givaudan is embedding functional formulation capabilities across diverse consumer touchpoints.
Providing physiological measurements offers brand clients concrete backing for wellness claims in a market segment historically reliant on subjective narrative. Replacing traditional consumer surveys with empirical biometric tracking provides prestige fragrance houses and consumer packaged goods manufacturers with verifiable data for products engineered to deliver functional stress-reduction benefits.
Commercial Deployment and Technical Metrics
Givaudan has not disclosed the launch date, geographic availability, commercial investment, partner terms, or the specific physiological stress markers captured by OrbiScanz™.
The critical metric to watch next is commercial uptake among prestige and mass-market brand clients, and whether products formulated via HarmoniScentz™ can establish a standardized benchmark for stress-alleviating claims in retail environments.
India’s second-generation direct-to-consumer beauty brands are recording operating revenue growth of 200% to 300% across digital retail channels, outpacing mature first-wave pioneers. The surge is driven by single-act...
Spanish biotech ingredient developer Vytrus Biotech unveiled Hydranode™, a bio-fermented osmolyte active designed to stimulate internal dermal water transport, at the in-cosmetics Asia 2026 trade exhibition in Bangkok...
